HLA polymorphisms in South Tunisian systemic sclerosis patients: a case-control study.

Area of Science:

• Immunogenetics
• Rheumatology
• Human Genetics

Background:

• Systemic sclerosis (SSc) is a complex autoimmune disease with suspected genetic underpinnings.
• Human Leukocyte Antigen (HLA) associations, particularly with HLA class II, are implicated in SSc pathogenesis across various populations.
• No prior studies have investigated HLA profiles in South Tunisian SSc patients.

Purpose of the Study:

• To investigate the Human Leukocyte Antigen (HLA) profile in South Tunisian patients diagnosed with Systemic Sclerosis (SSc).
• To identify specific HLA alleles associated with genetic susceptibility to SSc in this understudied population.

Main Methods:

• A case-control study design was employed, involving 19 SSc patients and 123 healthy controls.
• HLA class I (HLA-A, HLA-B) and class II (HLA-DRB1, HLA-DQB1) typing utilized microlymphocytotoxicity complement-dependent and polymerase chain reaction sequence specific primer (PCR-SSP) techniques.
• Statistical analyses were conducted using SPSS software and R language for robust data interpretation.

Main Results:

• The study identified significant associations between SSc and specific HLA alleles: HLA-DRB1*11 (pc=0.005), HLA-DQB1*03:01 (pc=0.002), and HLA-B53 (pc=0.01).
• The HLA-B53 association was found to be independent of HLA-DRB1*11.
• A highly significant difference in the B53-DRB1*11 haplotype distribution was observed between SSc patients and controls (13.15% vs. 0.8%, p < 1.33x10^-5).

Conclusions:

• In South Tunisia, Systemic Sclerosis (SSc) is associated with HLA-DRB1*11 and HLA-DQB1*03:01 alleles.
• Positive HLA-B53 status indicates increased susceptibility to SSc in this cohort.
• Further research is warranted to elucidate the complex associations between these HLA alleles and SSc pathogenesis.